Logo image
Sign in
PEMBROLIZUMAB PLUS CHEMOTHERAPY WITH OR WITHOUT BEVACIZUMAB IN PARTICIPANTS WITH PERSISTENT, RECURRENT, OR METASTATIC CERVICAL CANCER: 5-YEAR FOLLOW-UP RESULTS FROM KEYNOTE-826
Journal article   Peer reviewed

PEMBROLIZUMAB PLUS CHEMOTHERAPY WITH OR WITHOUT BEVACIZUMAB IN PARTICIPANTS WITH PERSISTENT, RECURRENT, OR METASTATIC CERVICAL CANCER: 5-YEAR FOLLOW-UP RESULTS FROM KEYNOTE-826

Kosei Hasegawa, Nicoletta Colombo, Krishnansu S. Tewari, Coraline Dubot, M. Valeria Cáceres, Domenica Lorusso, Ronnie Shapira-Frommer, Pamela Salman, Eduardo Yañez, Mahmut Gumus, …
International journal of gynecological cancer, Vol.35(11), p.102156
11/2025

Metrics

2 Record Views

Details

Logo image